Oct 30, 2025 04:16PM
Oct 30, 2025 07:01AM
Oct 29, 2025 07:02AM
Oct 23, 2025 06:03AM
Sep 30, 2025 07:01AM
Sep 10, 2025 06:01AM
Sep 4, 2025 07:39AM Kadimastem receives Hong Kong patent for diabetes therapy technology
May 21, 2025 07:30AM
Apr 15, 2025 09:02AM
Mar 31, 2025 09:12AM
Mar 31, 2025 09:10AM
Mar 10, 2025 07:04AM
Feb 27, 2025 07:05AM
Feb 10, 2025 07:31AM NLS Pharmaceutics (NLSP) and Kadimastem Unveil Multi-Target Approach to Diabetes, Expanding Beyond GLP-1 Therapies
Jan 31, 2025 07:31AM
Jan 30, 2025 07:32AM
Jan 28, 2025 07:32AM
Dec 30, 2024 07:31AM
Dec 19, 2024 07:31AM
Dec 19, 2024 07:30AM
Dec 11, 2024 07:32AM NLS Pharmaceutics (NLSP) CEO Issues Letter to Shareholders
Dec 11, 2024 07:30AM
Dec 4, 2024 01:15PM
Dec 3, 2024 07:41AM
Dec 3, 2024 07:40AM
Nov 18, 2024 07:30AM
Nov 4, 2024 07:03AM
Nov 4, 2024 07:00AM NLS Pharmaceutics and Kadimastem Enter into a Definitive Merger Agreement
Oct 28, 2024 07:02AM
Oct 28, 2024 07:00AM
Oct 21, 2024 07:03AM
Oct 21, 2024 07:00AM
Oct 15, 2024 07:00AM
Sep 25, 2024 08:04AM
Sep 25, 2024 08:00AM NLS Pharmaceutics Ltd. Announces Expected Implementation of 1-for-40 Reverse Share Split
Jul 29, 2024 07:02AM
Jul 29, 2024 07:00AM
Jul 29, 2024 06:57AM
Jun 28, 2024 09:02AM
Jun 28, 2024 09:00AM
Jun 27, 2024 08:45AM
Jun 27, 2024 08:07AM NLS Pharmaceutics (NLSP) Reports Promising Preclinical Results for Parkinson's Disease Treatments
Jun 27, 2024 08:00AM
Jun 27, 2024 08:00AM
Jun 27, 2024 08:00AM
Jun 25, 2024 09:13AM
Jun 25, 2024 08:30AM
Jun 11, 2024 08:32AM
Jun 11, 2024 08:30AM NLS Pharmaceutics Announces Publication of New Patent Application for Next-Gen Dual Non-Sulfonamide Orexin Receptor Agonists (DOXA)

397,112 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All